PD-1 Knockout Engineered T Cells

· The First Affiliated Hospital of Guangdong Pharmaceutical University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PD-1 Knockout Engineered T Cells, covering 2018-05-16 to 2020-12-21. Get the full timeline:

Most recent: Clinical Trial Update: PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer [Phase 1]